Safety and Target Engagement of Centella Asiatica in Cognitive Impairment

NCT05591027 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Alzheimer's Disease

Interventions

DRUG: Centella asiatica product
DRUG: Placebo

Sponsor

Oregon Health and Science University

Collaborators

[object Object]